TG Therapeutics Inc. | Key People and Executives
Michael Sean Weiss
Executive Chairman, President & CEO
Daniel Hume
Independent Director
Mark J. Schoenebaum
Independent Director
Kenneth Hoberman
Independent Director
Yann Echelard
Independent Director
William James Kennedy
Independent Director
Laurence N. Charney
Independent Director
Michael Sean Weiss
Executive Chairman, President & CEO
Sean A. Power
Chief Financial Officer, Secretary & Treasurer
Adam Waldman
Chief Commercial Officer
Jenna A. Bosco
Vice President-Investor Relations
Daniel Hume
Independent Director
Mark J. Schoenebaum
Independent Director
Kenneth Hoberman
Independent Director
Yann Echelard
Independent Director
William James Kennedy
Independent Director
Laurence N. Charney
Independent Director
| Address |
2 Gansevoort Street
New York New York 10014
United States
|
|
Employees
|
- |
| Website |
http://www.tgtherapeutics.com |
| Updated |
07/08/2019 |
| TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. It also involves developing TG-1101 and TGR-1202 therapies targeting hematological malignancies. The company was founded by Michael Sean Weiss and Laurence H. |
